Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Circulating tumor cells (CTCs) are the seeds of distant metastasis, and the number of CTCs detected in the blood of cancer patients is associated with a worse prognosis. CTCs face critical challenges for their survival in circulation, such as anoikis, shearing forces, and immune surveillance. Thus, understanding the mechanisms and interactions of CTCs within the blood microenvironment is crucial for better understanding of metastatic progression and the development of novel treatment strategies. CTCs interact with different hematopoietic cells, such as platelets, red blood cells, neutrophils, macrophages, natural killer (NK) cells, lymphocytes, endothelial cells, and cancer-associated fibroblasts, which can affect CTC survival in blood. This interaction may take place either via direct cell-cell contact or through secreted molecules. Here, we review interactions of CTCs with blood cells and discuss the potential clinical relevance of these interactions as biomarkers or as targets for anti-metastatic therapies. Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Citation

Thais Pereira-Veiga, Svenja Schneegans, Klaus Pantel, Harriet Wikman. Circulating tumor cell-blood cell crosstalk: Biology and clinical relevance. Cell reports. 2022 Aug 30;40(9):111298

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 36044866

View Full Text